(Q37303143)

19 August 2017

Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response (English)

1 reference

19 August 2017

1 reference

ultraviolet radiation

0 references

4

Garth H Utter

1 reference

19 August 2017

10

Michael P Busch

1 reference

19 August 2017

9

Harvey Alter

1 reference

19 August 2017

5

Cathy Schechterly

1 reference

19 August 2017

3

Douglas Bolgiano

1 reference

19 August 2017

11

Sherrill J Slichter

1 reference

19 August 2017

Rachael P Jackman

1

1 reference

19 August 2017

Xutao Deng

2

1 reference

19 August 2017

Mila Lebedeva

6

1 reference

19 August 2017

Eva Operskalski

7

1 reference

19 August 2017

Naomi L Luban

8

1 reference

19 August 2017

Philip J Norris

12

1 reference

19 August 2017

30 June 2013

1 reference

19 August 2017

1 reference

19 August 2017

54

1 reference

19 August 2017

3

1 reference

19 August 2017

672-680

1 reference

Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Distinct roles of trauma and transfusion in induction of immune modulation after injury

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Analysis of a high-throughput HLA antibody screening assay for use with platelet donors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Natural adjuvants: endogenous activators of dendritic cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Transfusion associated graft versus host disease in an immunocompetent patient

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Post-transfusion alloimmunization in patients with sickle cell disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

GVHD after transfusion of stored RBC concentrates in a solution of mannitol, adenine, phosphate, citrate, glucose, and NaCl following trauma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Suppression of transfusion-related alloimmunization in intensively treated cancer patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Prevention of refractoriness and HLA-alloimmunization using filtered blood products.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Alloimmunization in sickle cell anemia in the era of extended red cell typing.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

The natural history of alloimmunization to platelets

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

HCV viral load in anti‐HCV‐reactive donors and infectivity for their recipients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825847

Microdroplet Assay of Human Serum Cytotoxins

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FTRF.12317

Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation

21 January 2018

1 reference

12 December 2020

Alloimmunization following platelet transfusion: the absence of a dose-response relationship

1 reference

12 December 2020

Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study

1 reference

12 December 2020

Transfusion therapy and HLA antibody response in patients undergoing open heart surgery

1 reference

12 December 2020

A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia

1 reference

12 December 2020

Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions

1 reference

12 December 2020

Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization

1 reference

12 December 2020

Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration

1 reference

12 December 2020

Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease

1 reference

12 December 2020

The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions

1 reference

12 December 2020

Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease

1 reference

12 December 2020

Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial

1 reference

12 December 2020

Further observations on leukoagglutinin transfusion reactions in women: with special reference to leukoagglutinin transfusion reactions in women

1 reference

12 December 2020

Identifiers

DOI

10.1111/TRF.12317

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23808544

1 reference